A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer
- Authors
- Piao, Xuan-Mei; Kang, Ho Won; Jeong, Pildu; Byun, Young Joon; Lee, Hee Youn; Kim, Kyeong; Seo, Sung Phil; Kim, Won Tae; Lee, Jong-Young; Ha, Yun-Sok; Choi, Yung Hyun; Moon, Sung-Kwon; Yun, Seok Joong; Kim, Wun-Jae
- Issue Date
- Apr-2021
- Publisher
- Elsevier Inc.
- Keywords
- HLA-DRA; Immune biomarker; Muscle invasive bladder cancer; Nonmuscle invasive bladder cancer; Prognosis
- Citation
- Urologic Oncology: Seminars and Original Investigations, v.39, no.4, pp 237.e21 - 237.e29
- Journal Title
- Urologic Oncology: Seminars and Original Investigations
- Volume
- 39
- Number
- 4
- Start Page
- 237.e21
- End Page
- 237.e29
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/52499
- DOI
- 10.1016/j.urolonc.2020.11.017
- ISSN
- 1078-1439
1873-2496
- Abstract
- Background: There is an increasing demand for prognostic immune biomarkers of cancer. The prognostic significance of immune markers has been shown for various cancers, but biomarkers of bladder cancer (BCa) have not been fully evaluated. To clarify the role of human leukocyte antigen DR alpha chain (HLA-DRA) in BCa development, we examined expression of HLA-DRA mRNA in tissue samples of non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). Materials and Methods: Tissues of 96 NMIBC, 43 MIBC and 59 controls comprising noncancerous BCa surrounding tissues were used to examine the expression of HLA-DRA gene by real-time polymerase chain reaction. The expression of up-stream genes regulating HLA-DRA were also measured to explain the role of HLA-DRA in BCa. Results: Patients with high grade NMIBC showed higher expression of HLA-DRA than those with low grade NMIBC (P < 0.05). In addition, NMIBC patients who progressed to MIBC showed high expression of HLA-DRA mRNA. Kaplan-Meier analysis showed that NMIBC patients with low expression of HLA-DRA had better progression-free survival than those with high expression (P = 0.004). Moreover, the expression of genes regulating HLA-DRA varied in NMIBC and MIBC, indicating a different immunoregulation effect of HLA-DRA in both cancers. Conclusions: High expression of HLA-DRA in NMIBC patients has implications for patient stratification strategies, as well as for BCa tumor immunology. © 2020 Elsevier Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.